Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

AMH levels are higher in women with PCOS and can indicate the number of small follicles in their ovaries.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.

Genetics affect early female hair loss, severity depends on duration, and low ferritin levels not significant.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Women with moderate body hair have higher levels of certain hormones and may benefit from treatment that increases sex hormone-binding protein.

High levels of testosterone and anti-Müllerian hormone before pregnancy are linked to a higher risk of newborns needing intensive care.

Females have higher estrogen receptor levels in hair than males, and these levels decrease in white hair compared to black hair.

The ZIP7 gene helps control zinc levels in cells by moving zinc from the Golgi apparatus to the cytoplasm.

Environmental factors at different levels control hair stem cell activity, which could lead to new hair growth and alopecia treatments.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

A postmenopausal woman's increased male hormone levels were successfully treated with surgery.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

A postmenopausal woman's hirsutism and high testosterone levels improved after surgery for an ovarian tumor not seen on ultrasound.

Male hormones indirectly affect skin cell development by increasing growth factor levels from skin fibroblasts.

Some supplements and hormones can increase hair loss by raising DHT levels.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Chesapeake Bay retrievers' hair loss is likely a breed-specific, hereditary condition linked to abnormal steroid levels and distinct skin changes.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.